Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy. https://t.co/v3lniYSEIL
RT @sitcancer: New #JITC Short Report: Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy https://t.co/PZnjPUkpIh…
New #JITC Short Report: Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy https://t.co/PZnjPUkpIh https://t.co/Rd80BZW4JL
RT @Sussex_Haem: Interesting article out now in @BioMedCentral JITC by our colleague here at @SussexLifeSci @SussexUni Dr Paola Dama @paola…
RT @RhysMorganLab: Nice work @PaolaDama_1 and an interesting link with Wnt signalling to follow up! https://t.co/caZsfd57Hi
RT @Sussex_Haem: Interesting article out now in @BioMedCentral JITC by our colleague here at @SussexLifeSci @SussexUni Dr Paola Dama @paola…
RT @Sussex_Haem: Interesting article out now in @BioMedCentral JITC by our colleague here at @SussexLifeSci @SussexUni Dr Paola Dama @paola…
Nice work @PaolaDama_1 and an interesting link with Wnt signalling to follow up!
Interesting article out now in @BioMedCentral JITC by our colleague here at @SussexLifeSci @SussexUni Dr Paola Dama @paoladama_1 from her time at @UChicago @UChicagoMed examining the effect of Gal9/Tim3 expression on AML patient chemosensitivity https://t